-
We are with you: Hybribio donates 110,000 Rapid Antigen Tests to Hong Kong
In Hong Kong, the fifth wave of COVID-19 outbreak is raging and alarming. The Hybribio group is continually concerned about the development of the epidemic in Hong Kong. Hybribio group, in addition to
2022-03-30 古天乐代言太阳集团 60
-
A call of duty: Hybribio Victory air-inflated lab combats COVID-19 in Hong Kong
The fifth wave of COVID-19 outbreak hits Hong Kong along with variants Omicron and Delta. Since February, the number of confirmed cases has risen substantially, and Hong Kong confronts serious challen
2022-03-29 古天乐代言太阳集团 92
-
A big step forward! Hybribio’s HPV infection treatment solution ‘chloroquine phosphate gel’ won patents at home and abroad.
January is cervical cancer awareness month. Coincidentally, Hybribio makes a new process in developing therapeutic drugs for HPV infection. Hybribio subsidiaries (Hybribio Medicine & Guangzhou Hyb
2022-01-10 古天乐代言太阳集团 958
-
2021, a year full of honors. Hybribio was granted the “Golden Quality” Sustainable Growth Award.
A new journey comes after a new time. On the last day of 2021, the results of the "Golden Quality" Award for listed companies in 2021 were officially announced by Shanghai Securities News. B
2022-01-10 古天乐代言太阳集团 122
-
Double happiness! Hybribio was elected as "the Most Promising Listed Company in Biomedicine" and President K. C. Kun was awarded the "Best CEO of Listed Company".
On December 24, the Daily Economic News hosted the 10th China Listed Companies Summit Week of 2021. As an annual honorary ceremony in the Chinese capital market, it released the award ceremony of &quo
2022-01-04 古天乐代言太阳集团 80
-
A feast in biotechnology industry—the Innovation and Cooperation of Biotechnology Industry Chain (Hybribio Chaozhou) Forum
On December 11, the Innovation and Cooperation of Biotechnology Industry Chain Forum, jointly hosted by Hybribio and Fortune Capital, was held in Chaozhou, with the participation of academicians from
2021-12-17 古天乐代言太阳集团 51